Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

NCT05610202 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Malignancy

Interventions

DRUG: TQB3702 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.